In vitro and computational study demonstrates synergistic alpha-glucosidase inhibition by flavonoid mixtures, suggesting enhanced strategies for blood sugar management.
Naturally abundant flavonoids inhibit α-glucosidase (α-GLU), but the mechanisms underlying the synergistic effects among key active compounds remain poorly understood. In this study, the synergistic inhibition of α-GLU by hyperin, isoquercitrin, and quercetin was systematically investigated using fluorescence quenching, isothermal titration calorimetry, circular dichroism, differential scanning calorimetry, computational models, and Caco-2 cell assays. The ternary combination synergistically inhibited α-GLU (IC50 = 0.022 mg/mL, combination index <1) and showed the greatest α-helix reduction and denaturation temperature decrease of α-GLU. Molecular docking and molecular dynamics simulations suggested that quercetin preferentially occupied the hydrophobic catalytic pocket, whereas hyperin and isoquercitrin primarily interacted with peripheral regions. In differentiated Caco-2 cells, hyperin and isoquercitrin exhibited stronger inhibition toward sucrase than maltase, whereas quercetin showed the opposite trend. Collectively, the results demonstrate that the synergistic inhibition of α-GLU arises from complementary binding modes, cooperative conformational perturbation, and differential targeting of intestinal disaccharidase activities.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: